A Randomized, Double-Blind, 2-Period Crossover Trial to Determine the Relative Bioavailability of PM101 I.V. (Amiodarone HCl) and Cordarone I.V. in Healthy Adult Volunteers
Phase of Trial: Phase I
Latest Information Update: 16 Jan 2008
At a glance
- Drugs Amiodarone (Primary)
- Indications Ventricular arrhythmias
- Focus Pharmacokinetics
- Sponsors Prism Pharmaceuticals
- 16 Jan 2008 Status change from in progress to completed.
- 24 Jan 2007 New trial record.